[心脏综合征:历史方面和当前的挑战]
K S Nezhdanov1, L Y Milovanova2, L A Strizhakov1,2
1Lomonosov Moscow State University.
Terapevticheskii arkhiv
|December 30, 2023
概括
心脏综合征 (CRS) 涉及心脏和脏的相互作用,其理解从古代发展到现代研究. 目前的研究继续探索CRS分类和生物标志物.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医学史 医学史 医学史
背景情况:
- 自古以来,人们就已经认识到心脏和脏之间的病理生理关系.
- 希波克拉底和后来理查德·布莱特的早期观察强调了心脏和脏健康之间的联系.
- 术语"心脏病综合征" (CRS) 首次出现在20世纪初.
研究的目的:
- 追踪理解心脏与脏关系的历史演变.
- 记录心脏病综合征 (CRS) 的历史和里程碑.
- 提供关键数据和该领域的研究贡献的概述.
主要方法:
- 医学文献和关键出版物的历史综述.
- 科学贡献和术语发展的时间分析.
- 检查从古埃及到当代研究的开创性作品和研究.
主要成果:
- 心脏和脏相互作用的概念可以追溯到希波克拉底 (公元前13年).
- 关键的里程碑包括Gentile da Foligno的假设 (14世纪) 和Richard Bright的观察 (18世纪).
- 弗雷德里克·贾斯·科莱特 (Frederic Justin Collet) 于1903年首次使用"心脏药物";斯托尔尼科夫,塔雷耶夫 (Stolnikov,Tareev) 和继任者的俄罗斯研究显著推进了这一领域,导致2014年俄罗斯的指导方针.
结论:
- 对心综合征的理解有着悠久而丰富的历史.
- 持续的研究导致了重大进展,包括临床指南和共识报告.
- 目前正在进行的研究重点是关于尚未解决的问题,如CRS的分类,生物标志物和治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
01:22Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:29Renal Regulation of Acid-Base Balance
458
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
458
01:27Dialysis
320
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
320
01:06Renal Drug Clearance: Overview
207
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
207